Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | completed | Phase 1 / Phase 2 | 148 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT00620295 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Masonic Cancer Center, University of MinnesotaOTHER |
| 1 |
| Nov 29, 2017 |
| clinicaltrials |
| NCT00680667 | Clinical Trial of Trametes Versicolor in Women With Breast Cancer | completed | Phase 1 | 11 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 16 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00526617 | A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients | completed | Phase 1 | 41 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT01853306 | A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors | completed | Phase 1 | 71 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT02009631 | A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors | completed | Phase 1 | 45 | AbbVieINDUSTRY | 3 | Nov 20, 2017 | clinicaltrials |
| NCT00169533 | Rollover Study Of Lapatinib In Cancer Patients | completed | Phase 1 | 31 | GlaxoSmithKlineINDUSTRY | 3 | Nov 17, 2017 | clinicaltrials |
| NCT00388076 | Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) | completed | Phase 1 | 86 | GlaxoSmithKlineINDUSTRY | 1 | Nov 17, 2017 | clinicaltrials |
| NCT00650910 | Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer | completed | Phase 1 | 17 | GlaxoSmithKlineINDUSTRY | 3 | Nov 17, 2017 | clinicaltrials |
| NCT00849329 | A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer | completed | Phase 1 | 12 | GlaxoSmithKlineINDUSTRY | 3 | Nov 14, 2017 | clinicaltrials |
| NCT00359190 | Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer | completed | Phase 1 | 28 | GlaxoSmithKlineINDUSTRY | 2 | Nov 13, 2017 | clinicaltrials |
| NCT00722293 | A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors | completed | Phase 1 | 111 | GlaxoSmithKlineINDUSTRY | 2 | Nov 13, 2017 | clinicaltrials |
| NCT00821054 | A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients | completed | Phase 1 | 24 | GlaxoSmithKlineINDUSTRY | 3 | Nov 13, 2017 | clinicaltrials |
| NCT00996762 | A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib | completed | Phase 1 | 158 | GlaxoSmithKlineINDUSTRY | 2 | Nov 13, 2017 | clinicaltrials |
| NCT00581256 | A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer | completed | Phase 1 / Phase 2 | 54 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01046929 | Limonene Study in Women With Breast Cancer | completed | Phase 1 | 59 | University of ArizonaOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT01508572 | VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer | completed | Phase 1 | 20 | University Medical Center GroningenOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT02303366 | Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475(BOSTON II) | completed | Phase 1 | 15 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT00976339 | Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer | completed | Phase 1 | 20 | Katherine D. CrewOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT02658708 | Bright Light on Fatigue in Women Being Treated for Breast Cancer | completed | Phase 1 | 19 | Washington University School of MedicineOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01918254 | A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein | completed | Phase 1 | 66 | Hoffmann-La RocheINDUSTRY | 4 | Sep 12, 2017 | clinicaltrials |
| NCT01650506 | Study of Erlotinib and Metformin in Triple Negative Breast Cancer | completed | Phase 1 | 8 | Columbia UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01263145 | MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02015416 | A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer | completed | Phase 1 | 13 | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 1 | Aug 17, 2017 | clinicaltrials |
| NCT02135159 | Patients With Brain Metastases From HER2-positive Breast Cancer(BIRTH) | completed | Phase 1 | 36 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Aug 14, 2017 | clinicaltrials |
| NCT03246009 | Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients | completed | Phase 1 | 24 | Tianjin SinoBiotech Ltd.INDUSTRY | 1 | Aug 11, 2017 | clinicaltrials |
| NCT00594477 | Intensity Modulated Radiotherapy for Breast Cancer(IMRT) | completed | Phase 1 | 100 | Washington University School of MedicineOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT01104259 | Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer | completed | Phase 1 | 50 | University of WashingtonOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT01425476 | Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors | completed | Phase 1 / Phase 2 | 45 | Hartford HospitalOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT00788112 | Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast | completed | Phase 1 | 17 | University of California, San FranciscoOTHER | 1 | Aug 7, 2017 | clinicaltrials |
| NCT00764036 | Study of Artesunate in Metastatic Breast Cancer(ARTIC-M33/2) | completed | Phase 1 | 23 | Heidelberg UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00331552 | Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 30 | University of WashingtonOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT02496065 | Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery | completed | Phase 1 | 30 | Blaze Bioscience Inc.INDUSTRY | 1 | Jul 13, 2017 | clinicaltrials |
| NCT01105312 | Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 28 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT00637897 | Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 | 24 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00791037 | Vaccine Therapy in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 23 | University of WashingtonOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT01816035 | Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 13 | University of WashingtonOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT00058526 | A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer | completed | Phase 1 | 61 | GlaxoSmithKlineINDUSTRY | 5 | May 15, 2017 | clinicaltrials |
| NCT00004095 | Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 38 | Northwestern UniversityOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT01420146 | Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients(IJBMNZrT003) | completed | Phase 1 | 20 | Jules Bordet InstituteOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT00977275 | Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant | completed | Phase 1 / Phase 2 | 45 | Massachusetts General HospitalOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00934856 | A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 98 | Hoffmann-La RocheINDUSTRY | 4 | Apr 6, 2017 | clinicaltrials |
| NCT02406794 | Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors(KITMYCAN) | completed | Phase 1 / Phase 2 | 156 | University of MalagaOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT02391194 | Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery | completed | Phase 1 | 27 | Avelas Biosciences, Inc.INDUSTRY | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00379509 | Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 20 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT01390818 | Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 146 | EMD SeronoINDUSTRY | 3 | Mar 7, 2017 | clinicaltrials |
| NCT00719875 | HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer | completed | Phase 1 | 24 | Yale UniversityOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00086957 | Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 31 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Nov 29, 2017source: clinicaltrials